217 related articles for article (PubMed ID: 15370703)
1. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
Weischer M; Blum A; Eberhard F; Röcken M; Berneburg M
Acta Derm Venereol; 2004; 84(5):370-4. PubMed ID: 15370703
[TBL] [Abstract][Full Text] [Related]
2. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
4. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
6. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
Lin TL; Wu CY; Chang YT; Juan CK; Chen CC; Yu SH; Chen YJ
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis.
Kirke SM; Lowder S; Lloyd JJ; Diffey BL; Matthews JN; Farr PM
J Invest Dermatol; 2007 Jul; 127(7):1641-6. PubMed ID: 17380117
[TBL] [Abstract][Full Text] [Related]
8. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
9. The challenge of follow-up in narrowband ultraviolet B phototherapy.
Diffey BL; Farr PM
Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
[TBL] [Abstract][Full Text] [Related]
10. Safe and effective use of phototherapy and photochemotherapy in the treatment of psoriasis.
Campbell J
Br J Nurs; 2020 May; 29(10):547-552. PubMed ID: 32463760
[TBL] [Abstract][Full Text] [Related]
11. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
12. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
Jo SJ; Kwon HH; Choi MR; Youn JI
Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing Myth from Fact: Photocarcinogenesis and Phototherapy.
Thompson KG; Kim N
Dermatol Clin; 2020 Jan; 38(1):25-35. PubMed ID: 31753190
[TBL] [Abstract][Full Text] [Related]
14. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
Maiorino A; De Simone C; Perino F; Caldarola G; Peris K
J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study.
Chao CH; Wu CY; Chou FL; Chen YJ
Clin Exp Dermatol; 2024 Apr; 49(5):459-465. PubMed ID: 38056487
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic modalities for localized psoriasis: 308-nm UVB excimer laser versus nontargeted phototherapy.
Mudigonda T; Dabade TS; West CE; Feldman SR
Cutis; 2012 Sep; 90(3):149-54. PubMed ID: 23094316
[TBL] [Abstract][Full Text] [Related]
17. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
Mimouni I; Shulman J; Unes AA; Pavlovsky L; Pavlotsky F
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute.
Raone B; Patrizi A; Gurioli C; Gazzola A; Ravaioli GM
Photodermatol Photoimmunol Photomed; 2018 Sep; 34(5):302-306. PubMed ID: 29533483
[TBL] [Abstract][Full Text] [Related]
19. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
Asawanonda P; Nateetongrungsak Y
J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
